3-Cyano-5-fluoro-N-arylbenzamides as negative allosteric modulators of mGlu(5): Identification of easily prepared tool compounds with CNS exposure in rats.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2010-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2010.06.064PMID 20598884PMCID PMC2905502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Discovery and SAR of novel mGluR5 non-competitive antagonists not based on an MPEP chemotype.

  2009cited by this paper
• Recent progress in the discovery and development of negative allosteric modulators of mGluR5.

  2009cited by this paper
• Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming- and cue-induced reinstatement of cocaine seeking.

  2009cited by this paper
• A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease

  2009cited by this paper
• Discovery and SAR of 6-substituted-4-anilinoquinazolines as non-competitive antagonists of mGlu5.

  2009cited by this paper
• mGluR5 Antagonism Attenuates Methamphetamine Reinforcement and Prevents Reinstatement of Methamphetamine-Seeking Behavior in Rats

  2009cited by this paper
• Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.

  2009cited by this paper
• Synthesis and SAR of novel, non-MPEP chemotype mGluR5 NAMs identified by functional HTS.

  2009cited by this paper
• Interoceptive Effects of Alcohol Require mGlu5 Receptor Activity in the Nucleus Accumbens

  2009cited by this paper
• Dissociation of the Effects of MTEP [3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]piperidine] on Conditioned Reinstatement and Reinforcement: Comparison between Cocaine and a Conventional Reinforcer

  2009cited by this paper
• A pilot open label, single dose trial of fenobam in adults with fragile X syndrome

  2009cited by this paper
• Attenuation of cocaine self-administration in squirrel monkeys following repeated administration of the mGluR5 antagonist MPEP: comparison with dizocilpine

  2008cited by this paper
• Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold.

  2008cited by this paper
• mGluR5 antagonists: discovery, characterization and drug development.

  2008cited by this paper
• Cue-induced reinstatement of alcohol-seeking behavior is associated with increased ERK1/2 phosphorylation in specific limbic brain regions: blockade by the mGluR5 antagonist MPEP.

  2008cited by this paper
• mGlu5 receptor antagonists and their therapeutic potential

  2008cited by this paper
• Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice.

  2008cited by this paper
• Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonists.

  2007cited by this paper
• Comparison of the effects of mGluR1 and mGluR5 antagonists on the expression of behavioral sensitization to the locomotor effect of morphine and the morphine withdrawal jumping in mice.

  2007cited by this paper
• Behavioral and neurochemical interactions between Group 1 mGluR antagonists and ethanol: potential insight into their anti-addictive properties.

  2006cited by this paper
• Ionotropic and Metabotropic Glutamate Receptor Antagonism Attenuates Cue-Induced Cocaine Seeking

  2006cited by this paper
• Attenuation of Behavioral Effects of Cocaine by the Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)-pyridine in Squirrel Monkeys: Comparison with Dizocilpine

  2005cited by this paper
• Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats

  2005cited by this paper
• A Close Structural Analog of 2-Methyl-6-(phenylethynyl)-pyridine Acts as a Neutral Allosteric Site Ligand on Metabotropic Glutamate Receptor Subtype 5 and Blocks the Effects of Multiple Allosteric Modulators

  2005cited by this paper
• Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.

  2005cited by this paper
• 3-[Substituted]-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitriles: identification of highly potent and selective metabotropic glutamate subtype 5 receptor antagonists.

  2005cited by this paper
• Inhibition of transient lower esophageal sphincter relaxation and gastroesophageal reflux by metabotropic glutamate receptor ligands.

  2005cited by this paper
• Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers

  2005cited by this paper
• Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats.

  2005cited by this paper
• Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators.

  2005cited by this paper
• Transient lower esophageal sphincter relaxations in dogs are inhibited by a metabotropic glutamate receptor 5 antagonist.

  2005cited by this paper
• The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in Rodent Models of Anxiety

  2004cited by this paper
• Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking.

  2004cited by this paper
• Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling.

  2004cited by this paper
• Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential.

  2004cited by this paper
• Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities.

  2004cited by this paper
• The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse

  2003cited by this paper
• Development of a custom high-throughput preparative liquid chromatography/mass spectrometer platform for the preparative purification and analytical analysis of compound libraries.

  2003cited by this paper
• [3H]-methoxymethyl-MTEP and [3H]-methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor.

  2003cited by this paper
• 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity.

  2003cited by this paper
• Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice

  2001cited by this paper
• Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents.

  2000cited by this paper
• 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist.

  1999cited by this paper
• Pharmacological agents acting at subtypes of metabotropic glutamate receptors.

  1999cited by this paper
• Pharmacology and functions of metabotropic glutamate receptors.

  1997cited by this paper

• Pharmacological characterisation of allosteric modulators at human mGlu5.

  2025cites this paper
• Metabotropic glutamate receptors in GtoPdb v.2025.3

  2025cites this paper
• Metabotropic glutamate receptors in GtoPdb v.2023.1

  2023cites this paper
• Metabotropic glutamate receptors in GtoPdb v.2021.3

  2021cites this paper
• Profiling the Structural Determinants of Aryl Benzamide Derivatives as Negative Allosteric Modulators of mGluR5 by In Silico Study

  2020cites this paper
• Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology

  2019cites this paper
• Metabotropic glutamate receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• 1 Metabotropic Receptors for Glutamate and GABA

  2017cites this paper
• Synthesis and biological evaluation of picolinamides and thiazole-2-carboxamides as mGluR5 (metabotropic glutamate receptor 5) antagonists.

  2016cites this paper
• VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy

  2016cites this paper
• Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation

  2015cites this paper
• Discovery of potential negative allosteric modulators of mGluR5 from natural products using pharmacophore modeling, molecular docking, and molecular dynamics simulation studies

  2015cites this paper
• Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation s

  2015cites this paper
• Discovery of VU0431316: a negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.

  2014cites this paper
• Identification of specific ligand-receptor interactions that govern binding and cooperativity of diverse modulators to a common metabotropic glutamate receptor 5 allosteric site.

  2014cites this paper
• A novel class of succinimide-derived negative allosteric modulators of metabotropic glutamate receptor subtype 1 provides insight into a disconnect in activity between the rat and human receptors.

  2014cites this paper
• Substituted 1-Phenyl-3-(pyridin-2-yl)urea negative allosteric modulators of mGlu5: discovery of a new tool compound VU0463841 with activity in rat models of cocaine addiction.

  2013cites this paper
• Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.

  2013cites this paper
• Discovery of 2‐(2‐Benzoxazoyl amino)‐4‐Aryl‐5‐Cyanopyrimidine as Negative Allosteric Modulators (NAMs) of Metabotropic Glutamate Receptor 5 (mGlu5): From an Artificial Neural Network Virtual Screen to an In Vivo Tool Compound

  2012cites this paper
• Investigating Metabotropic Glutamate Receptor 5 Allosteric Modulator Cooperativity, Affinity, and Agonism: Enriching Structure-Function Studies and Structure-Activity Relationships

  2012cites this paper
• Metabotropic Receptors for Glutamate and GABA

  2012cites this paper
• Discovery of molecular switches within the ADX-47273 mGlu5 PAM scaffold that modulate modes of pharmacology to afford potent mGlu5 NAMs, PAMs and partial antagonists.

  2011cites this paper
• Fragile X syndrome: an update on developing treatment modalities.

  2011cites this paper
• (3-Cyano-5-fluorophenyl)biaryl negative allosteric modulators of mGlu(5): Discovery of a new tool compound with activity in the OSS mouse model of addiction.

  2011cites this paper
• Recent advances in the design and development of novel negative allosteric modulators of mGlu(5).

  2011cites this paper
• Discovery, synthesis, and structure-activity relationship development of a series of N-(4-acetamido)phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu(4)) with CNS exposure in rats.

  2011cites this paper
• Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulators.

  2010cites this paper